The Swiss Helvetia Fund Inc. (SWZ) At $12.60 Forms Top; EMISPHERE TECH (EMIS) SI Increased By 81.43%

December 8, 2017 - By Nellie Frank

The Swiss Helvetia Fund Inc. (SWZ) formed multiple top with $13.36 target or 6.00% above today’s $12.60 share price. The Swiss Helvetia Fund Inc. (SWZ) has $318.96M valuation. The stock decreased 0.32% or $0.04 during the last trading session, reaching $12.6. About 6,426 shares traded. The Swiss Helvetia Fund Inc. (NYSE:SWZ) has risen 24.39% since December 8, 2016 and is uptrending. It has outperformed by 7.69% the S&P500.

EMISPHERE TECH INCORPORATED (OTCMKTS:EMIS) had an increase of 81.43% in short interest. EMIS’s SI was 12,700 shares in December as released by FINRA. Its up 81.43% from 7,000 shares previously. With 69,200 avg volume, 0 days are for EMISPHERE TECH INCORPORATED (OTCMKTS:EMIS)’s short sellers to cover EMIS’s short positions. The stock decreased 2.63% or $0.01 during the last trading session, reaching $0.37. About shares traded. Emisphere Technologies, Inc. (OTCMKTS:EMIS) has 0.00% since December 8, 2016 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment decreased to 0.26 in Q2 2017. Its down 0.74, from 1 in 2017Q1. It fall, as 11 investors sold The Swiss Helvetia Fund Inc. shares while 27 reduced holdings. 6 funds opened positions while 4 raised stakes. 13.78 million shares or 14.43% less from 16.10 million shares in 2017Q1 were reported. Icon Advisers holds 0.24% or 266,767 shares in its portfolio. 3.24 million are held by 1607 Capital Prtnrs Ltd Company. First Republic Investment Mngmt Inc holds 0% or 31,818 shares. Smithfield holds 0.01% or 2,780 shares in its portfolio. Moreover, Sol Capital Mngmt Commerce has 0.04% invested in The Swiss Helvetia Fund Inc. (NYSE:SWZ). Morgan Stanley holds 0% or 23,336 shares in its portfolio. Ancora Advsr Ltd Liability Corporation accumulated 15,464 shares. Wolverine Asset Mngmt Ltd Liability Co holds 0.01% or 47,437 shares. 990 are owned by North Star Inv Corporation. Creative Planning holds 0% in The Swiss Helvetia Fund Inc. (NYSE:SWZ) or 775 shares. Guggenheim Cap Lc owns 22,130 shares or 0% of their US portfolio. Karpus, New York-based fund reported 1.14M shares. Bulldog Investors has 6.19% invested in The Swiss Helvetia Fund Inc. (NYSE:SWZ). Thomas J Herzfeld Advisors Incorporated accumulated 0.01% or 1,950 shares. Mariner Gru Limited Liability Company, New York-based fund reported 24,687 shares.

Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery firm in the United States. The company has market cap of $22.52 million. The firm offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It currently has negative earnings. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions.